• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[慢性肾衰竭患者血清及超滤液中中分子量成分的浓度]

[Concentration of medium molecular weight components in serum and ultrafiltrate in patients with chronic renal failure].

作者信息

Popławski A

机构信息

Kliniki Nefrologii AM w Białymstoku.

出版信息

Pol Tyg Lek. 1991;46(40-42):750-2.

PMID:1669151
Abstract

Comparable assays of medium molecular weight components in both serum and its ultrafiltrate in dialysed patients have shown, that an increase of such compounds levels in dialysis fluid is accompanied with their increase in the ultrafiltrate. No relationship between urea and medium molecular weight compounds content in both dialysate and serum was found.

摘要

对透析患者血清及其超滤物中中分子量成分的可比检测表明，透析液中此类化合物水平的升高伴随着其在超滤物中的增加。未发现透析液和血清中尿素与中分子量化合物含量之间存在关联。

相似文献

1
[Concentration of medium molecular weight components in serum and ultrafiltrate in patients with chronic renal failure].[慢性肾衰竭患者血清及超滤液中中分子量成分的浓度]
Pol Tyg Lek. 1991;46(40-42):750-2.
2
[Comparative examination of intermediate molecular weight compound values in both ultrafiltrate and blood of patients with chronic renal failure].[慢性肾衰竭患者超滤液和血液中中分子量化合物值的对比检测]
Pol Tyg Lek. 1993;48(20-22):452-4.
3
[Compounds of low and medium molecular weight in the blood ultrafiltrate of patients with chronic renal failure].[慢性肾功能衰竭患者血液超滤物中的低分子量和中分子量化合物]
Pol Tyg Lek. 1983 Oct 10;38(41):1277-80.
4
[Levels of dimethyl-L-arginine in ultrafiltrate and blood pressure in patients during hemodialysis].[血液透析患者超滤物中不对称二甲基精氨酸水平与血压]
Przegl Lek. 1995;52(9):431-5.
5
Calcium exposure and removal in chronic hemodialysis patients.慢性血液透析患者的钙暴露与清除
J Ren Nutr. 2006 Jan;16(1):41-6. doi: 10.1053/j.jrn.2005.10.006.
6
Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.腹膜透析患者透析液氧化蛋白与腹膜转运特性的关系
Nephrol Dial Transplant. 2008 Oct;23(10):3295-301. doi: 10.1093/ndt/gfn221. Epub 2008 Apr 28.
7
[Composition of amino acid in blood and dialysate by patients with in chronic renal insufficiency by peritoneal dialysis].[腹膜透析慢性肾功能不全患者血液和透析液中的氨基酸组成]
Vopr Pitan. 2008;77(3):45-8.
8
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.不同透析液的血液透析患者透析期间血清镁的变化及其与低血压发作的关系。
Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x.
9
The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis.序贯超滤和不同透析液钠浓度对血液透析期间血管稳定性的作用。
ASAIO J. 1993 Jul-Sep;39(3):M798-800.
10
[Effect of furosemide added to peritoneal dialysis fluid on hydroxyproline excretion in dialysate and urine].[添加速尿至腹膜透析液对透析液和尿液中羟脯氨酸排泄的影响]
Przegl Lek. 1994;51(7):300-2.